Terminal galactose residue on cell surface glycoproteins

The terminal galactose residue on cell surface glycoproteins refers to a carbohydrate (sugar) unit that occupies the outermost (terminal) position of N- or O-linked glycans decorating proteins on the plasma membrane. These motifs are recognized by endogenous lectins such as galectins, which mediate a broad range of cellular functions including cell signaling, immune response modulation, pathogen interaction, and tumor metastasis. Alterations in terminal glycosylation patterns—including sialylation and galactosylation—are frequently observed in cancer, inflammation, and infections and are used as disease biomarkers. However, this is not a specific protein or receptor that can be directly targeted by classical pharmaceutical agents. In summary: "Terminal galactose on cell surface glycoproteins" is a glycan motif, not a canonical protein target, and should not be classified as a discrete receptor, enzyme, or transporter. Its primary biological importance lies in its recognition by galectins and other lectins, influencing cell communication and disease processes.

Other names

Terminal β-galactose glycanTerminal galactose epitopeβ-galactoside (when referred to as a ligand for galectins)Galactose-terminated glycoprotein

Null for direct intervention. Indirect: Lectin (e.g., galectin) binding alters cell signaling, adhesion, immune cell recruitment, and tumor metastasis by interacting with terminal galactose motifs.